The Human Platelet antigens (HPAs) can be targets for alloimmune and autoimmune antibody responses that cause life-threatening bleeding disorders, such as refractoriness to platelet transfusions, post-transfusion purpura and neonatal alloimmune thrombocytopenia.
ThromboType®1 is a replacement for platelet serological testing to determine HPA-1. ThromboType1 contains the reagents necessary to identify an individual’s genotype for HPA-1 using a gel endpoint.1
- Less than 100 minutes from DNA to results
- Bufferless pre-cast gels included